Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health, and sustainability companies. The firm both funds and incubates companies.

Edwin Kania

Noubar Afeyan

Thomas de Vlaam

Flagship Pioneering

NEXTBio Capital invests in breakthrough medicine through application of next-generation technologies.

NEXTBio Capital

Stage 1 Ventures, LLC focuses on investing in disruptive Deep Tech and Science companies that are transforming global industries. The firm aims to be a bridge for early stage entrepreneurs by providing capital efficiency through their investment models.

Stage 1 Ventures, LLC

Life Science District S.r.l is involved in venture building and corporate innovation within the life sciences sector, focusing on the development, launch, and nurturing of start-ups to enhance health outcomes. The company supports intrapreneurship programs and open innovation strategies for corporates and SMEs.

Life Science District S.r.l

Tessera Therapeutics

Ring Therapeutics

Cellarity

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple transformative human health and sustainability products. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises 44 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, Moderna, Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics. 

Metric
Company Name	Flagship Pioneering	NEXTBio Capital	Stage 1 Ventures, LLC	Life Science District S.r.l
Symbol
MSH ID	COM:FLAGSHIPPIONEERING	COM:NEXTBIOCAPITAL	COM:STAGE1VENTURES	NET:LSDGROUP
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Life Sciences	Financial Services & Finance	Financial Services & Finance	Healthcare & Health Services
Industry	Venture Capital	Biotechnology	Venture Capital	Life Sciences
Country	US	US	US	IT
Stage
Employee Count	573
Website	flagshippioneering.com	nextbiocapital.com	stage1ventures.com	lsdgroup.net
LinkedIn	flagship-pioneering			lsd-group
Founders

Metric
Market Cap	60M
Enterprise Value
Monthly Web Traffic	41.00K	293
Web Traffic Growth	0.41	-0.39
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:FLAGSHIPPIONEERING

Flagship Pioneering

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue